Prostate Cancer Clinical Trials in Las Vegas, NV

Prostate Cancer Clinical Trials in Las Vegas, NV

View the best 10 prostate cancer medical studies in Las Vegas, Nevada. Access promising new therapies by applying to a Las Vegas-based Prostate Cancer clinical trial.

Trials in Las Vegas, Nevada

Here are the top 10 medical studies for prostate cancer in Las Vegas, Nevada

Image of Arizona Center for Cancer Care - Gilbert in Gilbert, United States.

ProstAtak® Immunotherapy

Cancer Vaccine

Recruiting1 awardPhase 3
This trial is testing ProstAtak® immunotherapy with radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak® kills cancer cells and helps the immune system learn to attack any remaining cancer cells, potentially improving treatment outcomes.
Image of Yale University- Yale Cancer Center in New Haven, United States.

Radium-223 +1 More

Radioactive Agent

Recruiting2 awardsPhase 3
This trial is comparing the efficacy of adding Radium-223 to Docetaxel chemotherapy versus Docetaxel chemotherapy alone in men with metastatic hormone-refractory prostate cancer.
Image of St. Vincent Frontier Cancer Center-Research ( Site 0037) in Billings, United States.

Enzalutamide +2 More

Hormone Therapy

Recruiting2 awardsPhase 3
This trial is testing a new drug called opevesostat for advanced prostate cancer patients who don't respond to usual care. The drug aims to stop the cancer from growing and spreading, potentially helping patients live longer.
Image of The Mayo Clinic - Phoenix in Phoenix, United States.

LHRH Analogue +3 More

Hormone Therapy

Recruiting2 awardsPhase 3
This trial is testing whether two different drugs can extend the time before cancer progresses in men with recurrent prostate cancer.
Image of City of Hope in Duarte, United States.

XmAb20717

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial will study the safety and effectiveness of XmAb20717 as a treatment for patients with metastatic prostate cancer who have been previously treated with other cancer therapies.
Image of NCT02257736 in Phoenix, United States.

Prednisone +2 More

Corticosteroid

Recruiting1 awardPhase 3
This trial tests apalutamide added to a standard treatment for advanced prostate cancer. It targets patients whose cancer has spread and who haven't had chemotherapy. The treatment works by blocking and lowering male hormones that help cancer grow. Apalutamide has shown efficacy in treating different stages of prostate cancer.
Image of Call for Information (Investigational Site 0005) in Los Angeles, United States.

Pembrolizumab +7 More

Checkpoint Inhibitor

Recruiting1 awardPhase 1 & 2
This trial tests pembrolizumab combined with other drugs in patients with advanced prostate cancer that doesn't respond to usual treatments. The treatment works by boosting the immune system to better attack cancer cells. Pembrolizumab has been previously tested in combination with chemotherapy for other cancers, showing improved response rates and progression-free survival.
Image of Exelixis Site #1 in Tucson, United States.

XL092

Recruiting1 awardPhase 1
This trial is testing a new drug called XL092 alone and with other cancer drugs in patients with advanced solid tumors. The goal is to see if these treatments can safely stop or slow tumor growth and help the immune system fight cancer more effectively.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Capivasertib +18 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.
Image of Veterans Administration Medical Center - Birmingham in Birmingham, United States.

TAK-700 +1 More

Androgen Synthesis Inhibitor

Recruiting2 awardsPhase 3
This trial is testing if a new drug called TAK-700 helps people with prostate cancer live longer than another drug called bicalutamide when used with ADT.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.